Skip to main content
VCbacked
Log inGet Started

Solid Biosciences

Charlestown, United States

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

$240.0M raised
Mar 2026
Post-IPO Equity
BiotechnologyGeneticsHealth CareMedical

Top Investors

RA Capital ManagementCormorant Asset ManagementPerceptive AdvisorsForesite CapitalJanus Henderson Investors

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Solid Biosciences

How much funding has Solid Biosciences raised?
Solid Biosciences has raised $240.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.
Who are Solid Biosciences's investors?
Solid Biosciences's investors include RA Capital Management, Cormorant Asset Management, Perceptive Advisors, Foresite Capital, Janus Henderson Investors.
Where is Solid Biosciences headquartered?
Solid Biosciences is headquartered in Charlestown, United States.
What does Solid Biosciences do?
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
What stage is Solid Biosciences at?
Solid Biosciences is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Solid Biosciences — Funding & Investors." VCBacked, March 6, 2026, https://www.vcbacked.co/company/solid-biosciences. Accessed July 9, 2026.
APA
VCBacked. (2026). Solid Biosciences — Funding & Investors. Retrieved July 9, 2026, from https://www.vcbacked.co/company/solid-biosciences
Wikipedia (cite web)
{{cite web |title=Solid Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/solid-biosciences |website=VCBacked |access-date=July 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
Renaissance BioScience
Vancouver$599K
AlpalifeBio
Woburn$9.8M
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K